Jin Ming-Jing, Li Yan-Ping, Zhou Huan-Si, Zhao Yu-Qian, Zhao Xiang-Pei, Yang Mei, Qin Mei-Jing, Lu Chun-Hua
Research Laboratory of Zhuang & Yao Medicine, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, 530200, China.
Medical Experimental Center, the First People's Hospital of Nanning, the Fifth Affiliated Hospital of Guangxi Medical University, Nanning, 530022, China.
Chin J Integr Med. 2025 Mar 7. doi: 10.1007/s11655-025-4121-5.
To evaluate the anti-hepatocellular carcinoma (HCC) activity of total alkaloids from Gelsemium elegans Benth. (TAG) in vivo and in vitro and to elucidate their potential mechanisms of action through transcriptomic analysis.
TAG extraction was conducted, and the primary components were quantified using high-performance liquid chromatography (HPLC). The effects of TAG (100, 150, and 200 µg/mL) on various tumor cells, including SMMC-7721, HepG2, H22, CAL27, MCF7, HT29, and HCT116, were assessed. Effects of TAG on HCC proliferation and apoptosis were detected by colony formation assays and cell stainings. Caspase-3, Bcl-2, and Bax protein levels were detected by Western blotting. In vivo, a tumor xenograft model was developed using H22 cells. Totally 40 Kunming mice were randomly assigned to model, cyclophosphamide (20 mg/kg), TAG low-dose (TAG-L, 0.5 mg/kg), and TAG high-dose (TAG-H, 1 mg/kg) groups, with 10 mice in each group. Tumor volume, body weight, and tumor weight were recorded and compared during 14-day treatment. Immune organ index were calculated. Tissue changes were oberseved by hematoxylin and eosin staining and immunohistochemistry. Additionally, transcriptomic and metabolomic analyses, as well as quatitative real-time polymerase chain reaction (RT-qPCR), were performed to detect mRNA and metabolite expressions.
HPLC successfully identified the components of TAG extraction. Live cell imaging and analysis, along with cell viability assays, demonstrated that TAG inhibited the proliferation of SMMC-7721, HepG2, H22, CAL27, MCF7, HT29, and HCT116 cells. Colony formation assays, Hoechst 33258 staining, Rhodamine 123 staining, and Western blotting revealed that TAG not only inhibited HCC proliferation but also promoted apoptosis (P<0.05). In vivo experiments showed that TAG inhibited the growth of solid tumors in HCC in mice (P<0.05). Transcriptomic analysis and RT-qPCR indicated that the inhibition of HCC by TAG was associated with the regulation of the key gene CXCL13.
TAG inhibits HCC both in vivo and in vitro, with its inhibitory effect linked to the regulation of the key gene CXCL13.
评估钩吻总生物碱(TAG)在体内和体外的抗肝细胞癌(HCC)活性,并通过转录组分析阐明其潜在作用机制。
进行TAG提取,使用高效液相色谱(HPLC)对主要成分进行定量。评估TAG(100、150和200μg/mL)对多种肿瘤细胞的影响,包括SMMC-7721、HepG2、H22、CAL27、MCF7、HT29和HCT116。通过集落形成试验和细胞染色检测TAG对HCC增殖和凋亡的影响。通过蛋白质印迹法检测半胱天冬酶-3、Bcl-2和Bax蛋白水平。在体内,使用H22细胞建立肿瘤异种移植模型。将40只昆明小鼠随机分为模型组、环磷酰胺(20mg/kg)组、TAG低剂量(TAG-L,0.5mg/kg)组和TAG高剂量(TAG-H,1mg/kg)组,每组10只。在14天的治疗期间记录并比较肿瘤体积、体重和肿瘤重量。计算免疫器官指数。通过苏木精和伊红染色及免疫组织化学观察组织变化。此外,进行转录组和代谢组分析以及定量实时聚合酶链反应(RT-qPCR)以检测mRNA和代谢物表达。
HPLC成功鉴定了TAG提取物的成分。活细胞成像和分析以及细胞活力测定表明,TAG抑制SMMC-7721、HepG2、H22、CAL27、MCF7、HT29和HCT116细胞的增殖。集落形成试验、Hoechst 33258染色、罗丹明123染色和蛋白质印迹法显示,TAG不仅抑制HCC增殖,还促进凋亡(P<0.05)。体内实验表明,TAG抑制小鼠HCC实体瘤的生长(P<0.05)。转录组分析和RT-qPCR表明,TAG对HCC的抑制作用与关键基因CXCL13的调控有关。
TAG在体内和体外均抑制HCC,其抑制作用与关键基因CXCL13的调控有关。